In the food industry, maintaining the integrity of barriers within the gastrointestinal tract is crucial for both safety and efficiency. Barrier integrity measurements help monitor and ensure that the gut barrier, essential for nutrient uptake, remains intact and functional. A compromised gut barrier can lead to the infiltration of harmful pathogens or toxins, potentially causing foodborne illnesses. Moreover, an effective gut barrier is vital for optimal nutrient absorption, ensuring that essential nutrients from food are properly absorbed into the body. By investing in barrier integrity measurements, consumer health is safeguarded, while enhancing the nutritional value of your products.
Locsense exhibitor at the SOT ToxExpo in Salt Lake City Locsense will exhibit at the 70th SOT Annual meeting and ToxExpo in Salt Lake City, Utah which will be held from the 10-14th of March 2024. The Society of Toxicology promotes the acquisition and utilization of knowledge in toxicology and aids in the protection of…
Read more
Locsense exhibitor at the Eurotox conference Meet us at the Eurotox conference, in the Ljubjana exhibition and convention center, which will be held from the 10th till the 13th of September 2023. For more details check the Eurotox 2023 website via the following link: https://www.eurotox2023.com/. Stop by our booth to learn more about our in-vitro…
Read more
Meet us at the MPS world summit in Berlin from 26th till the 30th of June. Find the latest results on blood-brain-barrier on chip development with impedance measurements for quality control presented by Robin Pampiermole from the Applied Stem Cell Technologies (AST) research group at the University of Twente. See poster number 92.
Read more
Chronic pulmonary diseases are a high burden on the healthcare system and on the quality of life (QoL)of its patients. As the third leading cause of death, chronic respiratory diseases have a tremendousmortality rate [1]. Moreover, with a prevalence of 300 million people worldwide, pulmonary diseases arenot only mortal but also highly prevalent [2]. The…
Read more
COPD is a major global cause of mortality, but current treatmentsonly provide symptomatic relief. Limited progress in developing new therapies is attributed to the absence of reliable lung models for testing.
Read more
Background Respiratory diseases are the 2nd leading cause of death globally. The current treatments for chronic lung diseases are only supportive. Very few new classes of therapeutics have been introduced for lung diseases in the last 40 years, due to the lack of reliable lung models that enable rapid, cost-effective, and high-throughput testing. To accelerate…
Read more